|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 12, Num. 3, 1995, pp. 188-189
|
Biotecnologia Aplicada 12(3): 188-189 (1995)
REPORTE CORTO / SHORT REPORT
INTERFERON ALPHA-2B IN EPIDEMIC NEUROPATHY
Pedro Lopez-Saura^1, Francisco Hernandez^1, Tania Gonzalez^1,
Violeta Labarta^1,Raul Valdes^1, Vivian Saez^1, Alain
Morlans^1 and Cuban Multicenter Group for Clinical Trials with
Interferon in Epidemic Neuropathy^2.
^1Center for Genetic Engineering and Biotechnology, P.O.
Box 6162, La Habana 6, Cuba. ^2"Abel Santamaria" Provincial
Hospital, Pinar del Rio; Center for Medical and Surgical
Research, Havana; Institute of Neurology and Neurosurgery,
Havana; "Calixto Garcia" General Hospital, Havana; "Salvador
Allende" General Hospital, Havana; "Joaquin Albarran" General
Hospital, Havana; "Luis Diaz Soto" High Institute for Military
Medicine Havana; "Gustavo Aldereguia" Provincial Hospital,
Cienfuegos; Villa Clara Provincial Hospital, Santa Clara;
"Camilo Cienfuegos" Provincial Hospital, Sancti Spiritus;
"Manuel Ascunce" Provincial Hospital, Camaguey; Santiago
Provincial Hospital, Santiago de Cuba and National Center for
Coordination of Clinical Trials.
Code Number: BA95080
Sizes of Files:
Text: 5K
No associated graphics
SUMMARY
More than 40 000 cases of an epidemic Neuropathy were
reported in Cuba during 1993. It had two clinical pictures: an
optic neuritis and a peripheral neuropathy. IFN treatment had
no additional effect, over the vitamin therapy, on the
evolution of the optic neuritis. A pooled, stratified,
analysis of all the trials indicates that IFN could be useful
for the treatment of the peripheral neuritis associated to the
epidemic neuropathy.
INTRODUCTION
More than 40 000 cases of an epidemic Neuropathy were
reported in Cuba during 1993. It had two clinical pictures: an
optic neuritis and a peripheral neuropathy (1). A nutritional
unbalance and toxic as well as opportunistic infectious agents
have been involved in the pathogeny of the disease. Several
virus isolates were obtained from patients cerebrospinal
fluid. One of them was identified as Coxsackie A9
serologically and by partial genome sequence. Its cytopathic
effect in vitro is sensitive to inhibition by IFN alpha
(2).
METHODS
Several controlled, randomized, clinical trials were carried
out with different treatments, among them IFN at various
therapeutic regimes, always compared to a basal polyvitamin
schedule that was given to all patients. Five IFN trials,
performed at 12 hospitals, included 212 patients with optic
neuritis and 460 with peripheral neurological symptoms
(including the control groups). Patients were less than 3
months sick. IFN alpha2b (Heberon, Heber Biotec, Havana) was
given 3 times per week during 3 weeks at 6, 3 or 1 mill. IU
per dose, depending on the trial.
RESULTS AND DISCUSSION
IFN treatment had no additional effect, over the vitamin
therapy, on the evolution of the optic neuritis. On the
contrary, 3 of the trials showed evidences of a beneficial
action of IFN on patients with the peripheral form of the
disease. Better results where obtained in the trial where the
higher dose (6 million IU) was used.
Twenty percent of the patients with IFN recovered after 21
days of treatment vs. 5% in the control group. After 1 month
of follow-up, there were significantly more recovered and less
worsened patients in the IFN group. In another trial, where
IFN (3 million IU) with or without hydroxocobalamine (as a
detoxifying agent) was used, there were also significantly
better results in the IFN groups than in those without it (70
vs. 56% improvement, 24 vs. 16% recovery, 5 vs. 20%
worsening).
A pooled, stratified, analysis of all the trials indicates
that IFN could be useful for the treatment of the peripheral
neuritis associated to the epidemic neuropathy.
REFERENCES
1.- RAM REZ, A.; R. RODR GUEZ; A. MARRERO; G. MESA; M. A.
GALINDO and L. INIGUEZ (1993). Neuropatia Epidemica: Breve
resena epidemiologica. Boletin Epidemiologico del Instituto
de Medicina Tropical "Pedro Kouri" Num. Especial
1:1-15.
2.- M S, P., M. P. RODR GUEZ, M. G. GUZM N, et
al.(1993). Resultados preliminares de laboratorio
virologico en estudios de casos de Neuropatia Epidemica.
Boletin Epidemiologico del Instituto de Medicina Tropical
"Pedro Kour" Num. Especial 1:7-8.
Copyright 1995 Sociedad Iberolatinamericana de Biotecnologia
Aplicada a la Salud
|